1983
DOI: 10.1016/s0140-6736(83)91685-9
|View full text |Cite
|
Sign up to set email alerts
|

Prognosis After Immunosuppression of Patients With Crescentic Nephritis Requiring Dialysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
24
1

Year Published

1985
1985
2000
2000

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 83 publications
(26 citation statements)
references
References 15 publications
1
24
1
Order By: Relevance
“…In three British series published in the mid 1980s, only 15 of 132 patients (I 1 %) were aged over 70 years,'"3 and in some series no patient was aged over 70 years. 4 TREATMENT AND OUTCOME Table 2 shows induction immunosuppression given in the first three months, together with outcome at three months and latest follow-up. Actual patient survival is shown in the figure.…”
Section: Discussionmentioning
confidence: 99%
“…In three British series published in the mid 1980s, only 15 of 132 patients (I 1 %) were aged over 70 years,'"3 and in some series no patient was aged over 70 years. 4 TREATMENT AND OUTCOME Table 2 shows induction immunosuppression given in the first three months, together with outcome at three months and latest follow-up. Actual patient survival is shown in the figure.…”
Section: Discussionmentioning
confidence: 99%
“…When the disease is not controlled by these measures, plasmapheresis has been advocated. It may be of particular value when the patient is oliguric (Hind et al 1983). Without plasmapheresis, very few anuric patients have recovered renal function.…”
Section: Diagnosismentioning
confidence: 99%
“…In such patients, if there is no sign of recovery after 3-4 weeks, immunosuppressive treatment should be reserved for controlling extrarenal vasculitis. Combined immunosuppression and plasmapheresis is associated with a high mortality from infection (Hind et al 1983).…”
Section: Diagnosismentioning
confidence: 99%
“…Our experience is that recovery can be achieved in almost all patients who still retain renal function at pre sentation [6], Application of this therapeutic approach to the RPGN associated with systemic vasculitides, such as Wegener's granulomatosis (WG) and microscopic polyarteritis (MP), was on an empirical basis initially, since the patho genesis of these disorders was unknown. Striking re sponses, even in patients who were dialysis dependent [7], encouraged us to carry out a randomised prospective con trolled trial (in which at entry the patients were stratified for level of renal function) to test whether plasma ex change enhanced the benefit carried by drug therapy alone. Results showed that the addition of plasma ex change to drug treatment was of significant benefit to the group of patients with the most advanced renal impair ment (dialysis dependent) [6; Pusey et al, in preparation] and provided a clue that humoral mechanisms might be important in pathogenesis.…”
Section: Introductionmentioning
confidence: 99%